Biblio
Ibrutinib treatment ameliorates murine chronic graft-versus-host disease. J Clin Invest. 2014.
T-cell transcriptional profiling and immunophenotyping uncover LAG3 as a potential significant target of immune modulation in multiple myeloma. Biol Blood Marrow Transplant. 2019.